Hepatitis D medical therapy

	Hepatitis Main Page
	Hepatitis D
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hepatitis D from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Hepatitis D medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatitis D medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatitis D medical therapy
CDC on Hepatitis D medical therapy
Hepatitis D medical therapy in the news
Blogs on Hepatitis D medical therapy
Directions to Hospitals Treating Hepatitis D
Risk calculators and risk factors for Hepatitis D medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]

Overview

The goal of treatment in hepatitis D is the clearance of the HDV and of the hepatitis B helper virus.

Monitoring HDV RNA and serological levels of HBsAg may help in management of these patients.^[1]

Follow-up for 6months may be recommended in these patients to evaluate for the development of chronic HBV and HDV infection.

↑ Manesis EK, Schina M, Le Gal F, Agelopoulou O, Papaioannou C, Kalligeros C, Arseniou V, Manolakopoulos S, Hadziyannis ES, Gault E, Koskinas J, Papatheodoridis G, Archimandritis AJ (2007). "Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring". Antiviral Therapy. 12 (3): 381–8. PMID 17591028. |access-date= requires |url= (help)